Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yishen Tongluo Formula (YSTLF) is a traditional Chinese medicine prescription, noted to be created by Professor Sun Zixue of Henan Provincial Hospital of Traditional Chinese Medicine. [5, 6] It is clinically investigated for treating conditions such as diabetic kidney disease, varicocele, and male infertility issues like oligoasthenozoospermia and idiopathic asthenozoospermia. [2, 5, 10] Studies indicate that the formula works through multiple mechanisms, including the regulation of the PI3K/Akt/mTOR and Sirt6/TGF-β1/Smad2/3 signaling pathways, modulation of apoptosis and inflammation, and exertion of antioxidant effects by reducing oxidative stress. [2, 5, 10, 12] As a traditional formula, its exact composition can vary between preparations, but commonly cited ingredients include herbs like Salvia miltiorrhiza, Epimedium brevicornum, and Astragalus membranaceus. [2, 3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yishen Tongluo Formula.